Anavex Life Sciences faces regulatory setbacks after the EMA adopted a negative opinion of blarcamesine in Alzheimer's. Find out why AVXL stock is a Sell.
SGOL offers direct, low-cost exposure to physical gold, holding $1.7m troy ounces at a 0.17% expense ratio. Read full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results